---
title: "The controlling shareholder of CHINA REFORM HEALTH and its concerted parties plan to invest 100 million to 200 million yuan to increase their shareholding"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/234930381.md"
description: "According to the Zhitong Finance APP, CHINA REFORM HEALTH announced that its controlling shareholder China Oceanwide Holdings Group Co., Ltd. (referred to as \"China Oceanwide\") and its concerted party Guoxin Development Investment Management Co., Ltd. (referred to as \"Guoxin Development\") plan to increase their holdings in the company within the next 6 months through methods permitted by the Shenzhen Stock Exchange, with an intended increase of no less than RMB 100 million and no more than RMB 200 million"
datetime: "2025-04-08T04:25:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/234930381.md)
  - [en](https://longbridge.com/en/news/234930381.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/234930381.md)
generator: "portal-rs"
---

# The controlling shareholder of CHINA REFORM HEALTH and its concerted parties plan to invest 100 million to 200 million yuan to increase their shareholding

According to the Zhitong Finance APP, CHINA REFORM HEALTH (000503.SZ) announced that its controlling shareholder China Oceanwide Holdings Group Co., Ltd. (referred to as "China Oceanwide") and its concerted party, China Reform Development Investment Management Co., Ltd. (referred to as "China Reform Development"), plan to increase their holdings in the company within the next six months through methods permitted by the Shenzhen Stock Exchange, with an intended increase of no less than RMB 100 million and no more than RMB 200 million

### Related Stocks

- [000503.CN](https://longbridge.com/en/quote/000503.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Schaeffler, CATL deepen EV partnership on battery management systems development](https://longbridge.com/en/news/296447490.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Jim Ratcliffe rescues vital British plastics factory from collapse](https://longbridge.com/en/news/296637993.md)
- [NRED Identifies Stronger Untested IP Targets Beyond 1.67% Copper Trench Mineralization at Wilmac | NREDF Stock News](https://longbridge.com/en/news/296612079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**